Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial ...

Regulatory expansion positions deucravacitinib 6 mg once daily as a first-in-class oral TYK2 option for active PsA, complementing its prior plaque psoriasis indication. POETYK PsA-1 showed significant ...

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Fans of Emmerdale have been left "crying my eyes out" after Cain Dingle's poignant cancer revelation. ITV soap fans will recall that Cain (Jeff Hordley) was shot by John Sugden (Oliver Farnworth) in ...

Researchers have found in a new study that among men with prostate cancer undergoing androgen deprivation therapy, use of oxybutynin 5 mg twice daily significantly reduced the frequency ...

The FDA approved this combination tablet in the same population late last year based on the AMPLITUDE study data.

Former ET co-host John Tesh revealed he that he far exceeded the wildest expectations of doctors who diagnosed him with ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

Roquefort Therapeutics is acquiring exclusive worldwide rights to a clinical-stage tumour inhibitor for £32m in an all-paper deal and raising £8.5 million.

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

The American Board of Regenerative Medicine has endorsed AEON Clinic, the first regenerative wellness facility in the Middle East, today unveiled its whole ...